MAIC of 177LuDOTATATE vs Sunitinib
177Lu-DOTATATE vs Sunitinib as Initial Treatment for Advanced Grade 2 Pancreatic Neuroendocrine Tumors Using Matching-Adjusted Indirect Comparison

Released: February 05, 2025

Expiration: August 04, 2025

Activity

Progress
1
Course Completed